SHENZHEN JIGUANGYUE TECHNOLOGY CO., LTD. – Trademark Portfolio

Entity Type: 22

SHENZHEN JIGUANGYUE TECHNOLOGY CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ANHOM. The owner is based in SHENZHEN.

LONGCHENG STREET, LONGGANG DISTRICT,

ROOM A212B014, BUILDING 4, TIANJIAN MODERN CITY, NO. 442 QINGLIN ROAD, HUANGGEKENG COMMUNITY,

SHENZHEN , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ANHOM
ANHOM
Registered 2024

Trademark Classifications

SHENZHEN JIGUANGYUE TECHNOLOGY CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does SHENZHEN JIGUANGYUE TECHNOLOGY CO., LTD. have?

SHENZHEN JIGUANGYUE TECHNOLOGY CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does SHENZHEN JIGUANGYUE TECHNOLOGY CO., LTD. file in?

SHENZHEN JIGUANGYUE TECHNOLOGY CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are SHENZHEN JIGUANGYUE TECHNOLOGY CO., LTD.'s most well-known trademarks?

SHENZHEN JIGUANGYUE TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as ANHOM. These are among 1 currently registered trademark in the portfolio.

What is SHENZHEN JIGUANGYUE TECHNOLOGY CO., LTD.'s trademark registration success rate?

SHENZHEN JIGUANGYUE TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.